Honours pharma companies with Outstanding Export Performance Award
Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently organised the 9th Edition of Outstanding Export Performance Award in Hyderabad.
InnoCare Pharma announced today that the first patient has been dosed in the Phase II/III clinical trial of its novel TYK2 inhibitor, Soficitinib (ICP-332), for the treatment patients with non-segmental vitiligo in China.
iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, announced the first use of the iotaSOFT? Insertion System outside of the United States.